Los Angeles Capital Management LLC Cytom X Therapeutics, Inc. Transaction History

Los Angeles Capital Management LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$3.87 - $7.39 $339,488 - $648,272	-87,723 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$4.32 - $6.43 $69,120 - $102,880	16,000 Added 22.31%	87,723 $447,000
Q2 2021 Aug 05, 2021	BUY	$6.33 - $9.91 $20,192 - $31,612	3,190 Added 4.65%	71,723 $454,000
Q1 2021 May 05, 2021	SELL	$6.6 - $9.0 $184,905 - $252,144	-28,016 Reduced 29.02%	68,533 $529,000
Q4 2020 Feb 04, 2021	SELL	$6.47 - $7.9 $23,841 - $29,111	-3,685 Reduced 3.68%	96,549 $632,000
Q3 2020 Nov 02, 2020	BUY	$6.55 - $8.83 $26,658 - $35,938	4,070 Added 4.23%	100,234 $667,000
Q2 2020 Aug 05, 2020	BUY	$7.4 - $14.64 $425,500 - $841,800	57,500 Added 148.72%	96,164 $801,000
Q1 2020 May 04, 2020	BUY	$3.61 - $8.6 $139,577 - $332,510	38,664 New	38,664 $297,000
Q2 2019 Jul 29, 2019	SELL	$9.35 - $11.41 $94,032 - $114,750	-10,057 Closed	0 $0
Q1 2019 Apr 25, 2019	SELL	$9.5 - $19.16 $101,460 - $204,628	-10,680 Reduced 51.5%	10,057 $108,000
Q4 2018 Feb 11, 2019	SELL	$12.69 - $18.61 $2,728 - $4,001	-215 Reduced 1.03%	20,737 $313,000
Q3 2018 Nov 05, 2018	BUY	$18.04 - $26.41 $81,540 - $119,373	4,520 Added 27.51%	20,952 $388,000
Q2 2018 Jul 31, 2018	BUY	$21.38 - $29.68 $9,193 - $12,762	430 Added 2.69%	16,432 $376,000
Q1 2018 Apr 27, 2018	SELL	$21.76 - $34.22 $8,486 - $13,345	-390 Reduced 2.38%	16,002 $455,000
Q4 2017 Feb 05, 2018	BUY	$19.0 - $23.09 $311,448 - $378,491	16,392	16,392 $346,000

50.7M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $69.9M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.